Nishiyama O - Search Results

1

Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia.

Nishiyama O, Miyajima H, Fukai Y, Yamazaki R, Satoh R, Yamagata T, Sano H, Iwanaga T, Higashimoto Y, Nakajima H, Kume H, Tohda Y. Nishiyama O, et al. Respir Med. 2013 Aug;107(8):1241-6. doi: 10.1016/j.rmed.2013.05.015. Epub 2013 Jun 25. Respir Med. 2013. PMID: 23806287 Free article. Clinical Trial.

2

The effectiveness of the visual analogue scale 8 in measuring health-related quality of life for COPD patients.

Nishiyama O, Taniguchi H, Kondoh Y, Nishimura K, Suzuki R, Takagi K, Yamaki K. Nishiyama O, et al. Respir Med. 2000 Dec;94(12):1192-9. doi: 10.1053/rmed.2000.0950. Respir Med. 2000. PMID: 11192955 Free article.

3

Effect of prolonged low-dose methylprednisolone therapy in acute exacerbation of idiopathic pulmonary fibrosis.

Nishiyama O, Shimizu M, Ito Y, Kume H, Suzuki R, Yokoi T, Yamaki K. Nishiyama O, et al. Respir Care. 2001 Jul;46(7):698-701. Respir Care. 2001. PMID: 11403701

4

Asthma health status: influence of disease severity categorized by peak expiratory flow.

Nishiyama O, Kato K, Kume H, Ito Y, Suzuki R, Yamaki K. Nishiyama O, et al. J Asthma. 2003 May;40(3):281-7. doi: 10.1081/jas-120018327. J Asthma. 2003. PMID: 12807172

5

Role of lysophosphatidylcholine in eosinophil infiltration and resistance in airways.

Nishiyama O, Kume H, Kondo M, Ito Y, Ito M, Yamaki K. Nishiyama O, et al. Clin Exp Pharmacol Physiol. 2004 Mar;31(3):179-84. doi: 10.1111/j.1440-1681.2004.03973.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15008962

6

Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.

Kondoh Y, Taniguchi H, Yokoi T, Nishiyama O, Ohishi T, Kato T, Suzuki K, Suzuki R. Kondoh Y, et al. Among authors: nishiyama o. Eur Respir J. 2005 Mar;25(3):528-33. doi: 10.1183/09031936.05.00071004. Eur Respir J. 2005. PMID: 15738299 Free article. Clinical Trial.

7

Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, Nishimura K. Nishiyama O, et al. Respir Med. 2005 Apr;99(4):408-14. doi: 10.1016/j.rmed.2004.09.005. Respir Med. 2005. PMID: 15763446 Free article.

8

Interstitial lung disease associated with gefitinib.

Kataoka K, Taniguchi H, Hasegawa Y, Kondoh Y, Kimura T, Nishiyama O, Imaizumi K, Kawabe T, Kume H, Shimokata K. Kataoka K, et al. Among authors: nishiyama o. Respir Med. 2006 Apr;100(4):698-704. doi: 10.1016/j.rmed.2005.07.015. Epub 2005 Aug 30. Respir Med. 2006. PMID: 16137874 Free article.

9

Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD.

Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Ogawa T, Watanabe F, Arizono S. Nishiyama O, et al. Respir Med. 2007 Apr;101(4):833-8. doi: 10.1016/j.rmed.2006.06.030. Epub 2006 Sep 8. Respir Med. 2007. PMID: 16962758 Free article.

10

Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.

Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Kume H, Shimokata K. Nishiyama O, et al. Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1016-21. doi: 10.1111/j.1440-1681.2006.04480.x. Clin Exp Pharmacol Physiol. 2006. PMID: 17042908 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters